Vimarsana
Biggest News Aggregation in the World

Page 14 - Allo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Allo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Allo Today - Breaking & Trending Today

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Receives Average Recommendation of "Moderate Buy" from Brokerages - Vimarsana News

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the twelve ratings firms that are covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and nine have given a buy recommendation […]

HC Wainwright Weighs in on Allogene Therapeutics, Inc.'s Q3 2023 Earnings (NASDAQ:ALLO) - Vimarsana News

HC Wainwright Weighs in on Allogene Therapeutics, Inc.'s Q3 2023 Earnings (NASDAQ:ALLO)

Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) – Investment analysts at HC Wainwright upped their Q3 2023 earnings per share estimates for shares of Allogene Therapeutics in a report issued on Monday, August 7th. HC Wainwright analyst R. Burns now forecasts that the company will post earnings per share of ($0.48) for the quarter, up […]

William Blair Analysts Lift Earnings Estimates for Allogene Therapeutics, Inc. (NASDAQ:ALLO) - Vimarsana News

William Blair Analysts Lift Earnings Estimates for Allogene Therapeutics, Inc. (NASDAQ:ALLO)

Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) – Investment analysts at William Blair boosted their Q3 2023 earnings estimates for Allogene Therapeutics in a research note issued on Thursday, August 3rd. William Blair analyst S. Corwin now anticipates that the company will post earnings per share of ($0.53) for the quarter, up from their prior […]

Allogene Therapeutics (NASDAQ:ALLO) Reaches New 12-Month Low at $4.27 - Vimarsana News

Allogene Therapeutics (NASDAQ:ALLO) Reaches New 12-Month Low at $4.27

Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) reached a new 52-week low during mid-day trading on Monday . The stock traded as low as $4.27 and last traded at $4.31, with a volume of 1199577 shares trading hands. The stock had previously closed at $4.59. Analyst Upgrades and Downgrades ALLO has been the topic […]

Allogene Therapeutics (NASDAQ:ALLO) Given New $18.00 Price Target at Truist Financial - Vimarsana News

Allogene Therapeutics (NASDAQ:ALLO) Given New $18.00 Price Target at Truist Financial

Allogene Therapeutics (NASDAQ:ALLO – Free Report) had its price target decreased by Truist Financial from $20.00 to $18.00 in a research report released on Wednesday, FlyOnTheWall reports. A number of other equities analysts also recently commented on ALLO. EF Hutton Acquisition Co. I reaffirmed a buy rating and set a $15.00 price objective on shares […]

Source: wkrb13.com